Amlodipine / atorvastatin Alternatives Compared
Amlodipine / atorvastatin | Repatha | Atorvastatin |
|
---|
Amlodipine / atorvastatin | Repatha (evolocumab) | Atorvastatin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for High Cholesterol, Angina, High Blood Pressure, Coronary Artery Disease, Prevention of Cardiovascular Disease. amlodipine / atorvastatin may also be used for purposes not listed in this... View more |
Prescription only
Repatha is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia and HoFH, and also to reduce the risk of cardiovascular events in adults with established... View more |
Prescription only
Atorvastatin is effective at lowering cholesterol; however, its use may be limited by side effects such as muscle pain. Prescribed for High Cholesterol, High Cholesterol - Familial Heterozygous... View more |
Related suggestions High Cholesterol
|
|||||||||||||||||||||||
More about Amlodipine / atorvastatin | More about Repatha (evolocumab) | More about Atorvastatin | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Amlodipine / atorvastatin has an average rating of 6.8 out of 10 from a total of 6 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
Repatha has an average rating of 5.2 out of 10 from a total of 643 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 46% reported a negative effect. |
Atorvastatin has an average rating of 4.3 out of 10 from a total of 294 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 56% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: amlodipine / atorvastatin side effects in more detail. |
See also: Repatha side effects in more detail. |
See also: atorvastatin side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
N/A |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all amlodipine / atorvastatin prices |
View all Repatha prices |
View all atorvastatin prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Caduet |
N/A |
Atorvaliq, Lipitor | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
50 hours |
408 hours |
14 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 727 drugs are known to interact with amlodipine / atorvastatin:
|
A total of 2 drugs are known to interact with Repatha:
|
A total of 383 drugs are known to interact with atorvastatin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
January 30, 2004 |
August 27, 2015 |
December 17, 1996 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.